Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of an $8 million senior secured term loan agreement with Natrix Separations, Inc. ("Natrix"). Proceeds of the loan will be used for working capital.

"Oxford is pleased to provide financing to Natrix Separations, a company that utilizes a unique technology for manufacturing single use chromatography products," said Christopher A. Herr, managing director for Oxford Finance. "The company, led by a talented management group, has been very successful with its product and is aggressively pursuing expansion opportunities into new markets."

Natrix CEO John Chickosky commented, "This financing is an important step for Natrix as we accelerate the commercial expansion of our company. The funding from Oxford will allow us to ramp up our product development efforts as we continue to change the way biopharmaceutical companies develop and manufacture important new therapeutics."

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $2 billion in loans, with lines of credit ranging from $500 thousand to $75 million.

Natrix Separations is a leading supplier of high performance, single use and multi-­cycle disposable chromatography products to the life science, food, beverage and water markets. Natrix Separations' patented AdvectiveTM chromatography technology combines the high binding capacity, selectivity and specificity associated with conventional resin-­based chromatography with the high throughput and ease-­of-­use of traditional membrane products.